Nanjing Vishee Medical Technology Co Ltd
SSE:688580

Watchlist Manager
Nanjing Vishee Medical Technology Co Ltd Logo
Nanjing Vishee Medical Technology Co Ltd
SSE:688580
Watchlist
Price: 33.92 CNY -0.21% Market Closed
Market Cap: 3.2B CNY
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one Nanjing Vishee Medical Technology Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 33.92 CNY, Nanjing Vishee Medical Technology Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Nanjing Vishee Medical Technology Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

7.5
P/S
P/S
Price to Sales
7.5
vs History
46
vs Industry
18
Median 3Y
9.8
Median 5Y
6.8
Industry
2.2
Forward
7
More Details
28.2
P/E
P/E
Price to Earnings
28.2
vs History
32
vs Industry
20
Median 3Y
28.2
Median 5Y
23.3
Industry
22.5
Forward
21.2
More Details
25.9
P/OCF
P/OCF
Price to OCF
25.9
vs History
41
vs Industry
14
Median 3Y
32.3
Median 5Y
22.1
Industry
13.9
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
4
Median 3Y
-363.7
Median 5Y
-627.6
Industry
19.7
More Details
2.1
P/B
P/B
Price to Book Value
2.1
vs History
60
vs Industry
41
Median 3Y
2.5
Median 5Y
2.5
Industry
2.1
More Details
5.1
EV/S
EV/S
Enterprise Value to Sales
5.1
vs History
41
vs Industry
24
Median 3Y
6.7
Median 5Y
4.3
Industry
2.3
Forward
4.8
More Details
7.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.3
vs History
41
vs Industry
31
Median 3Y
9.4
Median 5Y
6
Industry
4.9
More Details
22.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
22.3
vs History
36
vs Industry
15
Median 3Y
23.5
Median 5Y
16.6
Industry
11.9
Forward
14.9
More Details
22.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
22.3
vs History
36
vs Industry
20
Median 3Y
23.5
Median 5Y
16.6
Industry
16.4
Forward
13.6
More Details
17.7
EV/OCF
EV/OCF
Enterprise Value to OCF
17.7
vs History
39
vs Industry
23
Median 3Y
23.1
Median 5Y
13.8
Industry
13.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
6
Median 3Y
-273.3
Median 5Y
-387.4
Industry
17.2
More Details
3.2
EV/IC
EV/IC
Enterprise Value to IC
3.2
vs History
62
vs Industry
26
Median 3Y
6.5
Median 5Y
5.7
Industry
1.8
More Details

Multiples Across Competitors

Competitors Multiples
Nanjing Vishee Medical Technology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Nanjing Vishee Medical Technology Co Ltd
SSE:688580
3.2B CNY 7.5 28.2 22.3 22.3
US
Abbott Laboratories
NYSE:ABT
229.7B USD 5.5 17.1 23 33.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
176.4B USD 21.1 76 58.9 71.3
US
Boston Scientific Corp
NYSE:BSX
148.6B USD 8.9 80.2 36.7 51.7
US
Stryker Corp
NYSE:SYK
142B USD 6.3 47.4 24.6 29.7
IE
Medtronic PLC
NYSE:MDT
115.3B USD 3.5 27.1 14.4 20.3
US
Becton Dickinson and Co
NYSE:BDX
66.4B USD 3.2 38 15.8 28.5
DE
Siemens Healthineers AG
XETRA:SHL
55.5B EUR 2.4 28 16 22.9
US
Edwards Lifesciences Corp
NYSE:EW
42.7B USD 7.8 10.2 24 26.5
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
283.7B CNY 7.6 22.9 20 20
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.9B USD 1.9 18.5 12.9 15.8

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 242,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.